Edward Cantrall

Dr. Cantrall, a consultant to biotechnology and genomics companies, joined our Board of Directors in May 2002. He serves on the Board's audit committee. He was Vice President of Operations at Lederle Laboratories, a division of American Cyanamid Company subsequently acquired by Wyeth. His fields of expertise include pharmaceutical development and manufacturing. Dr. Cantrall holds a Ph.D. degree in organic chemistry from the University of Illinois and an M.B.A. degree in industrial management from Fairleigh Dickinson University.